Robinow syndrome with growth hormone deficiency: treatment with growth hormone.
We describe a 5 years and nine months old boy who presented with facial features, vertebral anomalies and dwarfism consistent with Robinow syndrome. Investigations revealed growth hormone (GH) deficiency to be the cause of his dwarfism. We reviewed data on four other patients with Robinow syndrome from the Genentech National Cooperative Growth Study (NCGS). Results of GH testing on three out of four were available and showed GH deficiency. Recombinant human GH therapy in our patient and the three patients from the NCGS resulted in a significant increase in the growth rate per year. The cause of dwarfism in children with Robinow syndrome has hitherto not been studied. We propose its association with GH deficiency and that treatment with rhGH can result in a significant increase in the growth rate of these children.
Department of Pediatrics, SUNY Health Science Center at Brooklyn, Children's Medical Center, USA.
S
S
Castells
A
A
Chakurkar
Q
Q
Qazi
W
W
Bastian
D001827:Body Height; D001846:Bone Development; D002675:Child, Preschool; D003241:Consanguinity; D004392:Dwarfism / Q000188:drug therapy* / Q000209:etiology*; D019382:Human Growth Hormone / Q000172:deficiency*; D006801:Humans; D008297:Male; D010375:Pedigree; D011994:Recombinant Proteins / Q000627:therapeutic use; D013577:Syndrome
D011994:Recombinant Proteins; D019382:Human Growth Hormone